Vaccine News and Research

Latest Vaccine News and Research

CoronaVac elicits lower antibody response than natural SARS-CoV-2 infection, study suggests

A recent study from Thailand highlights a rather low degree of neutralization-afforded protection mounted by the inactivated whole-virus CoronaVac vaccine compared to natural infection with SARS-CoV-2 – the virus that causes COVID-19.

30 Aug 2021

Researchers conduct an international study of vaccine hesitancy

The health beliefs model is one method of quantifying health behaviors. In a study recently published in the journal Vaccine, this method is utilized to specifically study COVID-19 vaccine hesitancy, bearing in mind that hesitancy is highly variable not only between individuals and location but also in regards to the specific medicine in question.

30 Aug 2021

Polymeric and lipid nanoparticles in self-amplifying RNA vaccines result in higher protein expression and immunogenicity

Self-amplifying RNA (saRNA) is an advanced platform for nucleic acid vaccine development. The backbone is typically derived from an alphaviral genome and encodes a gene of interest (GOI) and a viral replicase that can amplify the genomic and subgenomic RNA.

30 Aug 2021

Large Israeli study offers detailed look at safety profile of mRNA vaccine against SARS-CoV-2

A deep look into a nationwide mass vaccination setting in Israel revealed that the BNT162b2 (Pfizer–BioNTech) vaccine is not linked with an elevated risk of a majority of the adverse events under study, with the exception of myocarditis. However, even that potentially severe adverse event is much more pervasive following the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), found a new study published in the New England Journal of Medicine (NEJM).

30 Aug 2021

Next-gen COVID vaccine to make persistent neutralizing antibodies

Presently, there is a need to develop improved versions of COVID-19 vaccines that are effective against the SARS-CoV-2 variants of concern (VOC) and can confer long-term protection. Considering the need of the hour, scientists from the University of Sydney in Australia have generated a new COVID-19 vaccine CoVac-II and evaluated its effect against COVID-19 strains. The findings from this study are published on the bioRxiv* preprint server while awaiting peer review.

30 Aug 2021

Modeling of COVID-19 seroprevalence and resurgence in Canada

Despite increased vaccine distribution and a significant decrease in the number of COVID-19 cases in Canada, the future of the pandemic is still a major concern, based on the possibility of a resurgence in the short term as well as long term and an understanding of the future of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity. It is not clear if the Canadian population will reach herd immunity or if there is a risk of future resurgence of the virus in the Fall or Winter.

30 Aug 2021

Have SARS-CoV-2 symptoms changed in the UK population over time?

A new paper compares changes in the symptoms due to COVID-19 over the course of the pandemic.

29 Aug 2021

Assessing the risks of thrombotic events post vaccination with ChAdOx1 and BNT162b2 vaccines in England

Researchers aim to better understand the population-level thrombotic risks post COVID-19 vaccination with both the ChAdOx1-S and BNT162b2 vaccines.

29 Aug 2021

Pfizer COVID-19 jab side effects likely to be mild to moderate in extremely vulnerable 12-15 year olds

The side effects of the Pfizer-BioNTech jab against COVID-19 are likely to be mild to moderate and clear up quickly in 12-15 year olds at high risk of complications from the infection because of certain coexisting conditions, reveals a small study accepted for publication in the Archives of Disease in Childhood.

28 Aug 2021

Northwestern researchers continue investigation on all aspects of COVID-19 pandemic

Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.

28 Aug 2021

Bhutan starts immunizing children in the 12 to 19 age group against COVID-19

Bhutan is following up on its success in vaccinating 90 per cent of its adult population against COVID-19 by embarking on a plan to immunize children in the 12 to 19 age group.

27 Aug 2021

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen.

27 Aug 2021

Additional COVID-19 support deployed to the South West of England

From Friday 27 August additional support will be deployed to some local authorities in the South West of England.

27 Aug 2021

MS patients on anti-CD20 therapy have robust T cell responses to SARS-CoV-2 vaccination

Scientists have observed that MS patients exhibit a robust T cell response despite a reduced humoral response to COVID-19 vaccines. Read more here.

27 Aug 2021

Medicaid vaccination rates founder as states struggle to immunize their poorest residents

Medicaid enrollees are getting vaccinated against covid-19 at far lower rates than the general population as states search for the best strategies to improve access to the shots and persuade those who remain hesitant.

27 Aug 2021

States pull back on covid data even amid delta surge

Two state government websites in Georgia recently stopped posting updates on covid-19 cases in prisons and long-term care facilities, just as the dangerous delta variant was taking hold.

27 Aug 2021

Study examines safety of COVID-19 vaccine in a nationwide mass-vaccination setting

The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the safety of the Pfizer/BioNTech BNT162B2 vaccine against COVID-19.

27 Aug 2021

COVID-19 vaccine potency has diminished in recent months, but still helps in saving lives

COVID-19 vaccines remain effective, but their potency has diminished in recent months, according to a nationwide study at eight sites, including Salt Lake City, Utah.

27 Aug 2021

NIH HEAL Initiative leverages the strengths of communities to address opioid public health crisis

An article published in the Journal of the American Medical Association highlights the results of numerous strategies through which the National Institutes of Health's Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, is finding scientific solutions to address the nation's opioid crisis.

26 Aug 2021

German study shows high protection from COVID-19 in over 80s with Pfizer vaccine

A new observational study in Germany, recently published on the medRxiv* preprint server, found the Comirnaty vaccine to be 68.3% effective against COVID-19 for people over 80. In those fully immunized, the vaccine was found to be 73.2% effective in preventing hospitalization and 80.1% effective against death.

26 Aug 2021

Vaccine News and Research

Latest Vaccine News and Research

CoronaVac elicits lower antibody response than natural SARS-CoV-2 infection, study suggests

Researchers conduct an international study of vaccine hesitancy

Polymeric and lipid nanoparticles in self-amplifying RNA vaccines result in higher protein expression and immunogenicity

Large Israeli study offers detailed look at safety profile of mRNA vaccine against SARS-CoV-2

Next-gen COVID vaccine to make persistent neutralizing antibodies

Modeling of COVID-19 seroprevalence and resurgence in Canada

Have SARS-CoV-2 symptoms changed in the UK population over time?

Assessing the risks of thrombotic events post vaccination with ChAdOx1 and BNT162b2 vaccines in England

Pfizer COVID-19 jab side effects likely to be mild to moderate in extremely vulnerable 12-15 year olds

Northwestern researchers continue investigation on all aspects of COVID-19 pandemic

Bhutan starts immunizing children in the 12 to 19 age group against COVID-19

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

Additional COVID-19 support deployed to the South West of England

MS patients on anti-CD20 therapy have robust T cell responses to SARS-CoV-2 vaccination

Medicaid vaccination rates founder as states struggle to immunize their poorest residents

States pull back on covid data even amid delta surge

Study examines safety of COVID-19 vaccine in a nationwide mass-vaccination setting

COVID-19 vaccine potency has diminished in recent months, but still helps in saving lives

NIH HEAL Initiative leverages the strengths of communities to address opioid public health crisis

German study shows high protection from COVID-19 in over 80s with Pfizer vaccine

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in